Publications by authors named "J Hsia"
Patients with chronic limb threatening ischemia are at high risk for cardiovascular events, mortality, and adverse limb events. A 62-year-old man with diabetes and peripheral artery disease presented with a new foot ulcer with suspicion of infection. Leveraging evidence-based practices, a multidisciplinary team conducted a prompt and thorough evaluation.
View Article and Find Full Text PDFIntroduction: While left ventricular ejection fraction (LVEF) represents an important means by which to classify patients with heart failure (HF), relatively little is known about the distribution of LVEFs among patients hospitalized for HF based on their International Classification of Disease (ICD)-10 code.
Methods: We performed a retrospective cross-sectional analysis of patients admitted to a large integrated health system within the western US between January 1, 2018 and October 1, 2022 with a principal diagnosis of HF (defined by ICD-10 codes: I50.2, systolic HF; I50.
Background: Guideline-recommended hyperkalaemia management includes dietary potassium (K) restriction, bicarbonate correction, diuretics and K binders with dose reduction of renin-angiotensin-aldosterone system inhibitors as a last resort. The extent to which these recommendations are implemented is uncertain, as real-world data on hyperkalaemia management are limited. The Tracking Treatment Pathways in Adult Patients with Hyperkalemia (TRACK) study is a multinational, prospective, longitudinal study that is being conducted to address this knowledge gap.
View Article and Find Full Text PDFArticle Synopsis
- A hybrid operating room technique for pulmonary nodule localization offers a promising alternative to traditional two-stage methods, allowing for lesion localization during positive ventilation rather than in response to respiratory motion.
- A retrospective analysis of 176 patients compared localization accuracy between standard and lung-protective ventilator settings, with findings showing a significant improvement in accuracy using the higher tidal volume setting (8-10 mL/kg).
- The study identified tidal volume, nodule count, and localization depth as key factors affecting accuracy, suggesting that further randomized controlled trials are needed to confirm these results and set future clinical guidelines.
Article Synopsis
- The VOYAGER PAD study found that rivaroxaban 2.5 mg combined with aspirin reduced cardiovascular events but increased bleeding in patients with symptomatic peripheral artery disease (PAD) after revascularization.
- The study specifically looked at fragile patients, defined by age, weight, and kidney function, and assessed the drug's efficacy and safety for this group.
- Results showed fragile patients were at greater risk for ischemic events and bleeding, but the effectiveness of rivaroxaban was consistent across both fragile and nonfragile patients.